NeoStem to present adult stem cell technologies at Stem Cell Investor & Executive Networking Conference

May 28 2010

NeoStem, Inc. (NYSE Amex: NBS) ("NeoStem" or the "Company"), an international biopharmaceutical company with operations in the U.S. and China, announced that the Company has been invited to present its adult stem cell technologies at the Stem Cell Investor & Executive Networking Conference Event (SCIENCE) in New York City on June 1, 2010. SCIENCE is designed to bring together investors with industry executives, visionary researchers and clinicians and other stakeholders to highlight opportunities and discuss advances in the stem cell field.

Alan Harris, M.D., Ph.D., NeoStem's VP of Regenerative Medicine, Drug Development and Regulatory Affairs, has been selected to participate in the 11:30 am ET panel discussion on "Adult versus Embryonic" stem cells. Dr. Harris will highlight the positive attributes of and advances in adult stem cell research, as well as discuss the regenerative properties of very small embryonic-like stem cells without the controversy of traditional embryonic stem cells. The panel will be moderated by Martin Grumet, Ph.D., Professor of Cell Biology and Neuroscience, Division of Life Sciences, at Rutgers University. Additional panel participants will include Michael West, Ph.D., CEO of BioTime, Inc., and Michael Schuster, VP of Operations at Angioblast System, Inc.

At a 2:00 pm ET plenary session, Robin Smith, M.D., NeoStem's CEO and Chairman of the board of directors, will be a key speaker discussing "Autologous Approaches" to stem cell therapy, including the Company's experience as a pioneer in the field of autologous (one's own) adult stem cell banking and its potential applications for future therapies. Other speakers at this session will include Ronnda Bartel, Ph.D., the CSO of Aastrom Biosciences, Inc., Eldad Melamed, M.D., CMO of Brainstorm Cell Therapeutics and Madhusudan Peshwa, Ph.D., Executive VP of Cellular Therapies at MaxCyte, Inc.

Additionally, at 2:45 pm ET, Reverend Tomasz Trafny of the Vatican's Pontifical Council for Culture will be a keynote speaker at the conference to discuss the Church's growing support of the scientific and medical application of autologous adult stem cell and discuss the bioethical considerations. NeoStem and the Pontifical Council for Culture recently announced a joint initiative that unites their charitable organizations to expand research and raise awareness of adult stem cell therapies, including working on multiple collaborative activities to advance scientific research on adult stem cells, exploring their clinical application in the field of regenerative medicine and the cultural relevance of such a fundamental shift in medical treatment options.

"We are excited about another opportunity to highlight NeoStem's industry leading effort in the adult stem cell field, particularly with the recently announced joint initiative with the Pontifical Council for Culture," said Dr. Smith.

SOURCE NeoStem, Inc.